Research Article
Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection
Table 3
Preserved systolic function in Nrf2 KO mice as measured by cMRT (mean ± SD,
each).
| Parameter | Units | WT mice (mean ± SD) | Nrf2 KO mice (mean ± SD) | value |
| BM | (g) | 35.39 ± 2.55 | 33.41 ± 2.32 | 0.228 | Age | (d) | 219.50 ± 26.48 | 217.50 ± 28.49 | 0.911 | HF | (min−1) | 547.42 ± 49.56 | 519.17 ± 26.36 | 0.287 | EDV | (μl) | 52.03 ± 7.61 | 51.41 ± 5.80 | 0.888 | ESV | (μl) | 15.33 ± 3.98 | 15.89 ± 2.42 | 0.792 | SV | (μl) | 36.70 ± 4.38 | 35.52 ± 4.11 | 0.668 | EF | (%) | 70.86 ± 3.99 | 69.10 ± 2.81 | 0.439 | HZV | (ml/min) | 19.98 ± 2.17 | 18.47 ± 2.49 | 0.330 | m (D) | (mg) | 112.17 ± 16.00 | 119.62 ± 8.54 | 0.380 | rel. m | (mg/g) | 3.19 ± 0.56 | 3.59 ± 0.23 | 0.177 | dmitt (D) | (mm) | 1.09 ± 0.06 | 1.07 ± 0.06 | 0.646 | dmitt (S) | (mm) | 1.59 ± 0.10 | 1.60 ± 0.07 | 0.844 | WVmitt | (%) | 145.35 ± 7.31 | 149.24 ± 9.58 | 0.487 |
|
|